Prognostic value of serum CRP, IgM and IgA levels in children with Mycoplasma pneumoniae and pleural effusion

serum CRP, IgM and IgA levels in children with Mycoplasma pneumoniae

  • Huiqing Guo 1. Department of Pediatrics, Children's Hospital of Shanxi and Women’s Health Center of Shanxi, Taiyuan City, 030013, Shanxi Province, China
DOI: https://doi.org/10.5937/jomb0-54947
Keywords: Mycoplasma pneumoniae; Children; Pleural effusion; Clinical features; Predictors; Treatment outcome, CRP, IgM and IgA levels

Abstract


Objective: To analyze the clinical characteristics, predictive factors and curative effects of mycoplasma pneumoniae (MP) infection combined with pleural effusion in children.

Methods: The medical records of 200 children diagnosed with MP pneumonia in our hospital from January 2021 to December 2023 were retrospectively analyzed. According to the presence or absence of pleural effusion, all the children were divided into mycoplasma pneumoniae pneumonia (MPP) with pleural effusion group (100 cases) and MPP without pleural effusion group (100 cases). The differences in clinical manifestations, laboratory indicators, imaging examination, treatment plan and treatment effect between the two groups were compared. Multivariate Logistic regression model was used to analyze the potential predictors of MPP combined with pleural effusion.

Result: Age, length of hospital stay CRP level, white blood cell count, neutrophil count, IgM level, left lung disease, intravenous glucocorticoid use, duration of fever during hospitalization and duration of antibiotic use in MPP group were higher than those in group without pleural effusion (P<0.05). The number of cases, bilateral lung lesions and IgA levels in autumn were significantly lower than those in the group without pleural effusion (P<0.05). Multivariate Logistic regression analysis showed that age, CRP, white blood cell count, autumn infection, IgM and IgA levels were correlated with pleural effusion.

Conclusions: The predictors of MP infection with pleural effusion in children include age, CRP, WBC, autumn infection, IgM and IgA. These factors may contribute to the early identification and treatment of children with MP pneumonia combined with pleural effusion.

References

[1]Chiu, C.-Y., Chiang, L.-M., & Chen, T.-P. (2006). Mycoplasma pneumoniae infection complicated by necrotizing pneumonitis with massive pleural effusion. European journal of pediatrics, 165, 275-277.
[2]Cho, Y. J., Han, M. S., Kim, W. S., Choi, E. H., Choi, Y. H., Yun, K. W., Lee, S., Cheon, J.-E., Kim, I.-O., & Lee, H. J. (2019). Correlation between chest radiographic findings and clinical features in hospitalized children with Mycoplasma pneumoniae pneumonia. PLoS One, 14(8), e0219463.
[3]Han, C., Zhang, T., Zheng, J., Jin, P., Zhang, Q., Guo, W., & Xu, Y. (2022). Analysis of the risk factors and clinical features of Mycoplasma pneumoniae pneumonia with embolism in children: a retrospective study. Italian Journal of Pediatrics, 48(1), 1-11.
[4]Kim, S.-H., Lee, E., Song, E.-S., & Lee, Y.-Y. (2021). Clinical significance of pleural effusion in mycoplasma pneumoniae pneumonia in children. Pathogens, 10(9), 1075.
[5]Lee, K.-L., Lee, C.-M., Yang, T.-L., Yen, T.-Y., Chang, L.-Y., Chen, J.-M., Lee, P.-I., Huang, L.-M., & Lu, C.-Y. (2021). Severe Mycoplasma pneumoniae pneumonia requiring intensive care in children, 2010–2019. Journal of the Formosan Medical Association, 120(1), 281-291.
[6]Ling, Y., Zhang, T., Guo, W., Zhu, Z., Tian, J., Cai, C., & Xu, Y. (2020). Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infectious Diseases, 20, 1-8.
[7]Medjo, B., Atanaskovic-Markovic, M., Radic, S., Nikolic, D., Lukac, M., & Djukic, S. (2014). Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis. Italian Journal of Pediatrics, 40, 1-7.
[8]Nagayama, Y., Sakurai, N., & Yamamoto, K. (1990). Clinical observations of children with pleuropneumonia due to Mycoplasma pneumoniae. Pediatric pulmonology, 8(3), 182-187.
[9]Søndergaard, M. J., Friis, M. B., Hansen, D. S., & Jørgensen, I. M. (2018). Clinical manifestations in infants and children with Mycoplasma pneumoniae infection. PLoS One, 13(4), e0195288.
[10]Song, S., & Xu, Y. (2023). A retrospective study of the clinical characteristics of 9 children with pulmonary embolism associated with Mycoplasma pneumoniae pneumonia. BMC pediatrics, 23(1), 370.
[11]Su, D.-Q., Li, J.-F., & Zhuo, Z.-Q. (2020). Clinical analysis of 122 cases with mycoplasma pneumonia complicated with atelectasis: a retrospective study. Advances in therapy, 37, 265-271.
[12]Vervloet, L. A., Camargos, P. A. M., Soares, D. R. F., Oliveira, G. A. d., & Oliveira, J. N. d. (2010). Clinical, radiographic and hematological characteristics of Mycoplasma pneumoniae pneumonia. Jornal de Pediatria, 86, 480-487.
[13]Vervloet, L. A., Vervloet, V. E. C., Tironi Junior, M., & Ribeiro, J. D. (2012). Mycoplasma pneumoniae-related community-acquired pneumonia and parapneumonic pleural effusion in children and adolescents. Jornal Brasileiro de Pneumologia, 38, 226-236.
[14]Wang, J., Xia, C., Sharma, A., Gaba, G. S., & Shabaz, M. (2021). Chest CT findings and differential diagnosis of mycoplasma pneumoniae pneumonia and mycoplasma pneumoniae combined with streptococcal pneumonia in children. Journal of Healthcare Engineering, 2021.
[15] Wang Guanling, Hu Binfei. Risk factors analysis of pleural effusion in hospitalized children with mycoplasma pneumoniae pneumonia [J]. Journal of Medical Research,2017,46(02):142-144.
[16] Zheng Baoying, Yan Chao, Xue Guanhua, et al. Analysis of clinical characteristics and epidemic genotypes in children with drug-resistant mycoplasma pneumoniae pneumonia [J]. Chinese Journal of Practical Pediatrics, 2017, 32(10): 735 -- 739.
[17] YAN C, XUE G, ZHAO H, et al. Molecular and Clinical Characteristics of Severe Mycoplasma Pneumoniae Pneumonia in Children[J]. Pediatric Pulmonology, 2019,54(7):1012–1021.
[18] Ling, Y., Zhang, T., Guo, W., Zhu, Z., Tian, J., Cai, C., & Xu, Y. (2020). Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children. BMC Infectious Diseases, 20. https://doi.org/10.1186/s12879-020-05270-6.
[19] Lee, E., & Lee, Y. (2021). Predictive Factors of the Responses to Treatment of Mycoplasma pneumoniae Pneumonia. Journal of Clinical Medicine, 10. https://doi.org/10.3390/jcm10061154.
Published
2025/04/08
Issue
Vol. 44 No. 6 (2025): Journal of Medical Biochemistry
Section
Original paper

Copyright (c) 2025 Chao Chen

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The published articles will be distributed under the Creative Commons Attribution 4.0 International License (CC BY). It is allowed to copy and redistribute the material in any medium or format, and remix, transform, and build upon it for any purpose, even commercially, as long as appropriate credit is given to the original author(s), a link to the license is provided and it is indicated if changes were made. Users are required to provide full bibliographic description of the original publication (authors, article title, journal title, volume, issue, pages), as well as its DOI code. In electronic publishing, users are also required to link the content with both the original article published in Journal of Medical Biochemistry and the licence used.

Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.